Perigon Wealth Management, LLC - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 1 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Perigon Wealth Management, LLC ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$090.0%0.00%
Q4 2017$090.0%0.00%
Q3 2017$090.0%0.00%
Q2 2017$090.0%0.00%
Q1 2017$090.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Prospera Financial Services Inc 90,800$140,0000.03%
Spark Investment Management LLC 90,800$139,0000.02%
Cambridge Investment Research Advisors, Inc. 27,219$42,0000.00%
Vantage Investment Advisors, LLC 1,150$2,0000.00%
Balentine LLC 55$00.00%
Capital Advisors, Ltd. LLC 177$00.00%
UBS Group AG 6,211$10,0000.00%
BLACKROCK ADVISORS LLC 5,453$8,0000.00%
Wealthspire Advisors, L.P. 207$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 283$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders